Is Fortrea Holdings Inc. (FTRE) overvalued? · rev $2.72B
Fortrea Holdings Inc. (FTRE) is a biotechnology company listed on US.
This page asks whether Fortrea Holdings Inc. (FTRE) looks expensive on cached numbers — not a short thesis.
Latest reported FTRE revenue for 2025-12-31 was $2.72B. Net income was -$986.2M. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. FTRE currently screens at market cap $433.7M.
FTRE currently screens at market cap $433.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next FTRE 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the FTRE stock page for the full model, not this heading.
Not investment advice.